Qi-En Wang, PhD
College of Medicine
Molecular Carcinogenesis and Chemoprevention
>DNA Damage ● Cancer ● Ovarian Cancer ● Xeroderma Pigmentosum ● Leukemia, Myeloid, Acute ● Thyroid Cancer ● Multiple Myeloma ● Glioblastoma ● Carcinoma, Non-Small-Cell Lung
Qi-En Wang, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where he focuses his research on the regulation of the DNA repair pathway nucleotide excision repair and its connection to cancer therapy.In particular, he seeks to understand DNA damage response in cancer stem cells and their role in chemotherapy resistance development. One of his recent studies indicates that transcription factors CREB1 and FoxA1 have a novel global transcriptional co-regulatory function and their signaling is a targetable driver of the progress of prostate cancer. Dr. Wang is the co-author of many articles in well-respected publications, including Nucleic Acids Research, Journal of Biological Chemistry, Cancer Research and Molecular & Cellular Oncology.